Stocks and Investing
Stocks and Investing
Mon, September 24, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 21, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Charles Duncan Initiated (CARA) at Buy and Held Target at $27 on, Sep 21st, 2018
Charles Duncan of Cantor Fitzgerald, Initiated "Cara Therapeutics, Inc." (CARA) at Buy and Held Target at $27 on, Sep 21st, 2018.
Charles has made no other calls on CARA in the last 4 months.
There are 4 other peers that have a rating on CARA. Out of the 4 peers that are also analyzing CARA, 0 agree with Charles's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Charles
- Matthew Andrews of "Jefferies" Initiated at Strong Buy and Held Target at $30 on, Thursday, September 13th, 2018
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $24 on, Wednesday, August 15th, 2018
- Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, August 8th, 2018
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018